<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Glaucomatocyclitic Crisis (Posner-Schlossman Syndrome) - EyeWiki</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"mdy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ZAVjV6GOq7JQLtpI71Nb2AAAAAc","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)","wgTitle":"Glaucomatocyclitic Crisis (Posner-Schlossman Syndrome)","wgCurRevisionId":85387,"wgRevisionId":85387,"wgArticleId":1735,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles","Glaucoma","Uveitis"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)","wgRelevantArticleId":1735,"wgIsProbablyEditable":!1,
"wgRelevantPageIsProbablyEditable":!1,"wgRestrictionEdit":[],"wgRestrictionMove":[],"sdgDownArrowImage":"/w/extensions/SemanticDrilldown/skins/down-arrow.png","sdgRightArrowImage":"/w/extensions/SemanticDrilldown/skins/right-arrow.png","wgCiteDrawerEnableDesktop":!1,"wgCiteDrawerEnableMobile":!0,"wgCiteDrawerTheme":"dark","wgPageFormsTargetName":null,"wgPageFormsAutocompleteValues":[],"wgPageFormsAutocompleteOnAllChars":!1,"wgPageFormsFieldProperties":[],"wgPageFormsCargoFields":[],"wgPageFormsDependentFields":[],"wgPageFormsCalendarValues":[],"wgPageFormsCalendarParams":[],"wgPageFormsCalendarHTML":null,"wgPageFormsGridValues":[],"wgPageFormsGridParams":[],"wgPageFormsContLangYes":null,"wgPageFormsContLangNo":null,"wgPageFormsContLangMonths":[],"wgPageFormsHeightForMinimizingInstances":800,"wgPageFormsShowOnSelect":[],"wgPageFormsScriptPath":"/w/extensions/PageForms","edgValues":[],"wgPageFormsEDSettings":null,"wgAmericanDates":!0,"wgVisualEditor":{"pageLanguageCode":"en"
,"pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"srfFilteredConfig":null,"wgEditSubmitButtonLabelPublish":!1};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.ui.button":"ready","skins.chameleon":"ready","zzz.ext.bootstrap.styles":"ready","mediawiki.toc.styles":"ready","ext.CookieWarning.styles":"ready","oojs-ui-core.styles":"ready","oojs-ui.styles.indicators":"ready","mediawiki.widgets.styles":"ready","oojs-ui-core.icons":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.srf.styles":"ready","ext.smw.style":"ready","ext.smw.tooltip.styles":"ready"};RLPAGEMODULES=["ext.smw.style","ext.smw.tooltips","ext.cite.ux-enhancements","smw.entityexaminer","site","mediawiki.page.startup","mediawiki.page.ready","mediawiki.toc","ext.citedrawer.main","ext.CookieWarning","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eyeWiki",
"ext.eyeWiki.slideshow","sentry.init","ext.bootstrap.scripts"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.CookieWarning.styles%7Cext.cite.styles%7Cext.visualEditor.desktopArticleTarget.noscript%7Cmediawiki.toc.styles%7Cmediawiki.ui.button%7Cmediawiki.widgets.styles%7Coojs-ui-core.icons%2Cstyles%7Coojs-ui.styles.indicators%7Cskins.chameleon%7Czzz.ext.bootstrap.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.smw.style%7Cext.smw.tooltip.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.srf.styles&amp;only=styles&amp;skin=chameleon"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=chameleon"></script>
<style>#mw-indicator-mw-helplink {display:none;}</style>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=chameleon"/>
<meta name="generator" content="MediaWiki 1.35.8"/>
<meta name="description" content="Posner-Schlossman Syndrome (PSS), also known as glaucomatocyclitic crisis, is a disease typified by acute, unilateral, recurrent attacks of elevated intraocular pressure (IOP) accompanied by mild anterior chamber inflammation. The pathophysiology is still unknown, although there are several theories proposed, ranging from autoimmune to infectious. Treatment management is focused on controlling the intraocular pressure and decreasing inflammation. While an attack usually resolves without sequelae, repeated attacks over time may lead to long-term glaucomatous damage (a secondary glaucoma)."/>
<meta name="date" content="2022-05-11"/>
<meta name="WT.seg_1" content="0"/>
<meta name="google-site-verification" content="mtQvMIGqpWB4oyYM5mux15MHU-3qWI0bWtyRa2b5rlk"/>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
<link rel="alternate" type="application/rdf+xml" title="Glaucomatocyclitic Crisis (Posner-Schlossman Syndrome)" href="/w/index.php?title=Special:ExportRDF/Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)&amp;xmlmime=rdf"/>
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="EyeWiki (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="https://eyewiki.org/w/api.php?action=rsd"/>
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,400&display=swap" rel="stylesheet">
<!-- Favicons MEYE-108 -->
<link rel="apple-touch-icon" sizes="120x120" href="/w/extensions/EyeWiki/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/w/extensions/EyeWiki/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/w/extensions/EyeWiki/favicons/favicon-16x16.png">
<link rel="manifest" href="/w/extensions/EyeWiki/favicons/site.webmanifest">
<link rel="mask-icon" href="/w/extensions/EyeWiki/favicons/safari-pinned-tab.svg" color="#603cba">
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico">
<meta name="msapplication-TileColor" content="#603cba">
<meta name="msapplication-config" content="/w/extensions/EyeWiki/favicons/browserconfig.xml">
<meta name="theme-color" content="#ffffff">
<script> window.interdeal = { "sitekey": "81c701489fb8bb4ab90ca1cb0931f9c5", "Position": "Left", "Menulang": "EN", "domains": { "js": "https://cdn.equalweb.com/", "acc": "https://access.equalweb.com/" }, "btnStyle": { "vPosition": [ "80%", null ], "scale": [ "0.8", "0.8" ], "color": { "main": "#1876c9" }, "icon": { "type": 1, "outline": false } } }; (function(doc, head, body){ var coreCall = doc.createElement('script'); coreCall.src = 'https://cdn.equalweb.com/core/4.3.8/accessibility.js'; coreCall.defer = true; coreCall.integrity = 'sha512-u6i35wNTfRZXp0KDwSb3TntaIKI2ItCt/H/KcYIsBeVbaVMerEQLBnU5/ztfBg9aSW1gg7AN4CqCu9a455jkUg=='; coreCall.crossOrigin = 'anonymous'; coreCall.setAttribute('data-cfasync', true ); body? body.appendChild(coreCall) : head.appendChild(coreCall); })(document, document.head, document.body); </script>
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Glaucomatocyclitic_Crisis_Posner-Schlossman_Syndrome rootpage-Glaucomatocyclitic_Crisis_Posner-Schlossman_Syndrome layout-standard skin-chameleon action-view">
	<div class="flex-fill container">
		<div class="row">
			<div class="flex-grow-0 col-12 col-cmln-6 d-flex flex-column flex-md-row w-md-100 justify-content-start align-items-center col">
					<div class="float-left mr-3 mb-2"><a href="//aao.org"><img id="aao-logo" src="/w/extensions/EyeWiki/skins/chameleon/AAO_Logo.png"></a></div>
                		
				<!-- logo and main page link -->
				<div id="p-logo" class="p-logo" role="banner">
					<a href="/Main_Page" title="Visit the main page"><img src="/w/extensions/EyeWiki/skins/chameleon/EyeWiki_Logo.png" alt="EyeWiki"/></a>
				</div>
			</div>
			<div class="ml-auto col-12 col-cmln col">
				<div class="row">
					<div class="col">
						<!-- personal tools -->
						<div class="p-personal pull-right" id="p-personal" >
							<ul class="p-personal-tools" >
								<li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Glaucomatocyclitic+Crisis+%28Posner-Schlossman+Syndrome%29" title="You are encouraged to create an account and log in; however, it is not mandatory" class="pt-createaccount">Create account</a></li>
								<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Glaucomatocyclitic+Crisis+%28Posner-Schlossman+Syndrome%29" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o" class="pt-login">Log in</a></li>
							</ul>
						</div>

					</div>
				</div>
				<div class="row">
					<div class="col">
						<!-- search form -->
						<div  id="p-search" class="p-search pull-right" role="search"  >
							<form  id="searchform" class="mw-search" action="/w/index.php" >
								<input type="hidden" name="title" value=" Special:Search" />
								<div class="input-group">
									<input name="search" placeholder="Search EyeWiki" title="Search EyeWiki [f]" accesskey="f" id="searchInput" class="form-control"/>
									<div class="input-group-append">
										<button value="Go" id="searchGoButton" name="go" type="submit" class="search-btn searchGoButton" aria-label="Go to page" title="Go to a page with this exact name if it exists"></button>
									</div>
								</div>
							</form>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar collapsible mb-3 mt-2 p-1 mt-cmln-0" role="navigation" id="mw-navigation">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#hbpzyuu0u8"></button>
					<div class="collapse navbar-collapse hbpzyuu0u8" id="hbpzyuu0u8">
						<div class="navbar-nav"><div class="nav-item"><a class="nav-link fas fa-home"  href="/Main_Page">Main Page</a></div><div class="nav-item"><a class="nav-link fas fa-book"  href="/Category:Articles">Articles</a></div><div class="nav-item"><a class="nav-link fas fa-play"  href="/Help:Getting_Started">Getting Started</a></div><div class="nav-item"><a class="nav-link fas fa-question"  href="/Help:Contents">Help</a></div><div class="nav-item"><a class="nav-link fas fa-backward"  href="/Special:RecentChanges">Recent changes</a></div><div class="nav-item"><a class="nav-link fas fa-door-open"  href="#">My Portal</a></div>
						</div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- Content navigation -->
				<div class="mb-3 pagetools p-contentnavigation" id="p-contentnavigation">
					<!-- namespaces -->
					<div id="p-namespaces" class="p-namespaces">
						<div class="tab-group">
							<div id="ca-nstab-main" class="selected"><a href="/Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)" title="View the content page [c]" accesskey="c" class="selected ca-nstab-main">Page</a></div>
							<div id="ca-talk" class="new"><a href="/w/index.php?title=Talk:Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)&amp;action=edit&amp;redlink=1" rel="discussion" title="Discussion about the content page (page does not exist) [t]" accesskey="t" class="new ca-talk">Discussion</a></div>
						</div>
					</div>
					<!-- views -->
					<div id="p-views" class="p-views">
						<div class="tab-group">
							<div id="ca-formedit"><a href="/w/index.php?title=Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)&amp;action=formedit" title="Edit this page with a form [&amp;]" accesskey="&amp;" class="ca-formedit">View form</a></div>
							<div id="ca-viewsource"><a href="/w/index.php?title=Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e" class="ca-viewsource">View source</a></div>
							<div id="ca-history"><a href="/w/index.php?title=Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class="ca-history">History</a></div>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">

			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- start the content area -->
				<div id="content" class="mw-body content"><a id="top" class="top"></a>
					<div id="mw-indicators" class="mw-indicators">
					<div id="mw-indicator-smw-entity-examiner" class="mw-indicator mw-indicator-smw-entity-examiner"><div class="smw-entity-examiner smw-indicator-vertical-bar-loader" data-subject="Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)#0##" data-dir="ltr" data-uselang="" title="Running an examiner in the background"></div></div>
				</div>
						<div class="contentHeader">
						<!-- title of the page -->
						<h1 id="firstHeading" class="firstHeading">Glaucomatocyclitic Crisis (Posner-Schlossman Syndrome)</h1>
						<!-- tagline; usually goes something like "From WikiName" primary purpose of this seems to be for printing to identify the source of the content -->
						<div id="siteSub" class="siteSub">From EyeWiki</div><div id="jump-to-nav" class="mw-jump jump-to-nav">Jump to:<a href="#mw-navigation">navigation</a>, <a href="#p-search">search</a></div>
					</div>
					<div id="bodyContent" class="bodyContent">
						<!-- body text -->

						<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div id="article-header" data-description2-ignore=""><div id="contest" style="margin-bottom: 6px;">
</div>
<div class="infobox contributors">
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/Property:Authors" title="Property:Authors">Article initiated by</a>:
</div>
<div class="info-section-body"><a href="/User:Crystal.Hung" title="User:Crystal.Hung">Crystal Hung, MD</a>,&#8201;<a href="/User:JoAnn_A_Giaconi_MD" title="User:JoAnn A Giaconi MD">JoAnn A. Giaconi, MD</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">All authors and contributors:
</div>
<div class="info-section-body"> <a href="/User:Sarwat.Salim.SEC" title="User:Sarwat.Salim.SEC">Sarwat Salim MD, FACS</a>,&#160;<a href="/User:John.Davis.Akkara" title="User:John.Davis.Akkara">Dr John Davis Akkara (MBBS, MS, FAEH, FMRF)</a>,&#160;<a href="/User:Alan.Palestine" title="User:Alan.Palestine">Alan Palestine, MD</a>,&#160;<a href="/User:Jennifer.Cao" title="User:Jennifer.Cao">Jennifer Cao, MD</a>,&#160;<a href="/User:Manishi.Desai" title="User:Manishi.Desai">Manishi Desai, MD</a>,&#160;<a href="/User:Leonard.K.Seibold" title="User:Leonard.K.Seibold">Leonard K. Seibold, MD</a>,&#160;<a href="/User:Crystal.Hung" title="User:Crystal.Hung">Crystal Hung, MD</a>,&#160;<a href="/User:Qi.cui" title="User:Qi.cui">Qi N. Cui, MD PhD</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Assigned editor:
</div>
<div class="info-section-body"> <a href="/User:Qi.cui" title="User:Qi.cui">Qi N. Cui, MD PhD</a>,&#32;<a href="/User:Jennifer.Cao" title="User:Jennifer.Cao">Jennifer Cao, MD</a></div>
</div><div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Review:
</div>
<div class="info-section-body">Assigned status <b>Update Pending</b>
</div>
</div>&#160;by <a href="/User:Qi.cui" title="User:Qi.cui">Qi N. Cui, MD PhD</a> on May 12, 2022.
</div>
<div style="display:none;">
<table cellspacing="5">

<tbody><tr>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)&amp;action=formedit">add</a></small>
</td></tr>
<tr>
<th align="right"><b><a href="/Property:Contributing_Editors" title="Property:Contributing Editors">Contributing Editors</a>:</b>
</th>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)&amp;action=formedit">add</a></small>
</td></tr>
</tbody></table>  </div>
<div style="display:none;">
<p><br />
</p>
</div>
<div id="local-videos">
</div>
</div>
<div class="infobox vertical">
<div class="info-section vertical" style="margin-bottom: 10px;">
<div class="info-section-header">Glaucomatocyclitic Crisis (Posner-Schlossman Syndrome)
  </div>
<div class="info-section-body">
  </div>
</div>
<div class="info-section horizontal" style="margin-bottom: 10px;">
<div class="info-section-header"><a rel="nofollow" class="external text" href="http://en.wikipedia.org/wiki/Diseases_Database">DiseasesDB</a>
        </div>
<div class="info-section-body"><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb34624.htm">34624</a>
        </div>
</div>
</div>
<p><br />
</p><p>Posner-Schlossman Syndrome (PSS), also known as glaucomatocyclitic crisis, is a disease typified by acute, unilateral, recurrent attacks of elevated intraocular pressure (IOP) accompanied by mild anterior chamber inflammation. The pathophysiology is still unknown, although there are several theories proposed, ranging from autoimmune to infectious. Treatment management is focused on controlling the intraocular pressure and decreasing inflammation. While an attack usually resolves without sequelae, repeated attacks over time may lead to long-term glaucomatous damage (a secondary glaucoma). 
</p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Disease_Entity"><span class="tocnumber">1</span> <span class="toctext">Disease Entity</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Disease"><span class="tocnumber">1.1</span> <span class="toctext">Disease</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Epidemiology"><span class="tocnumber">1.2</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Pathology.2FPathophysiology"><span class="tocnumber">1.3</span> <span class="toctext">Pathology/Pathophysiology</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-5"><a href="#Diagnosis"><span class="tocnumber">2</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-6"><a href="#History"><span class="tocnumber">2.1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Exam_findings"><span class="tocnumber">2.2</span> <span class="toctext">Exam findings</span></a></li>
<li class="toclevel-2 tocsection-8"><a href="#Ancillary_testing"><span class="tocnumber">2.3</span> <span class="toctext">Ancillary testing</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Laboratory_studies"><span class="tocnumber">2.4</span> <span class="toctext">Laboratory studies</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Associations"><span class="tocnumber">2.5</span> <span class="toctext">Associations</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Differential_diagnosis"><span class="tocnumber">2.6</span> <span class="toctext">Differential diagnosis</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-12"><a href="#Management"><span class="tocnumber">3</span> <span class="toctext">Management</span></a>
<ul>
<li class="toclevel-2 tocsection-13"><a href="#Medical_therapy"><span class="tocnumber">3.1</span> <span class="toctext">Medical therapy</span></a></li>
<li class="toclevel-2 tocsection-14"><a href="#Surgical_therapy"><span class="tocnumber">3.2</span> <span class="toctext">Surgical therapy</span></a></li>
<li class="toclevel-2 tocsection-15"><a href="#Follow_up"><span class="tocnumber">3.3</span> <span class="toctext">Follow up</span></a></li>
<li class="toclevel-2 tocsection-16"><a href="#Prognosis"><span class="tocnumber">3.4</span> <span class="toctext">Prognosis</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-17"><a href="#Possible_Etiologies"><span class="tocnumber">4</span> <span class="toctext">Possible Etiologies</span></a>
<ul>
<li class="toclevel-2 tocsection-18"><a href="#Autonomic_dysregulation"><span class="tocnumber">4.1</span> <span class="toctext">Autonomic dysregulation</span></a></li>
<li class="toclevel-2 tocsection-19"><a href="#Allergy"><span class="tocnumber">4.2</span> <span class="toctext">Allergy</span></a></li>
<li class="toclevel-2 tocsection-20"><a href="#Variation_of_developmental_glaucoma"><span class="tocnumber">4.3</span> <span class="toctext">Variation of developmental glaucoma</span></a></li>
<li class="toclevel-2 tocsection-21"><a href="#Vascular_endothelial_dysfunction"><span class="tocnumber">4.4</span> <span class="toctext">Vascular endothelial dysfunction</span></a></li>
<li class="toclevel-2 tocsection-22"><a href="#Autoimmune.2FHLA-Bw54"><span class="tocnumber">4.5</span> <span class="toctext">Autoimmune/HLA-Bw54</span></a></li>
<li class="toclevel-2 tocsection-23"><a href="#Infectious"><span class="tocnumber">4.6</span> <span class="toctext">Infectious</span></a>
<ul>
<li class="toclevel-3 tocsection-24"><a href="#H._pylori"><span class="tocnumber">4.6.1</span> <span class="toctext"><i>H. pylori</i></span></a></li>
<li class="toclevel-3 tocsection-25"><a href="#HSV.2FVZV"><span class="tocnumber">4.6.2</span> <span class="toctext">HSV/VZV</span></a></li>
<li class="toclevel-3 tocsection-26"><a href="#CMV"><span class="tocnumber">4.6.3</span> <span class="toctext">CMV</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-27"><a href="#References"><span class="tocnumber">5</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h1><span class="mw-headline" id="Disease_Entity">Disease Entity</span></h1>
<h2><span class="mw-headline" id="Disease">Disease</span></h2>
<p>Posner and Schlossman first reported a series of 9 cases&#160;and coined&#160;the term&#160;“glaucomatocyclitic crisis” in 1948.<sup id="cite_ref-PosnerSchlossman_1-0" class="reference"><a href="#cite_note-PosnerSchlossman-1">&#91;1&#93;</a></sup>&#160;These patients suffered from recurrent unilateral attacks of ocular hypertension that shared the following characteristics:<sup id="cite_ref-2" class="reference"><a href="#cite_note-2">&#91;2&#93;</a></sup> 
</p>
<ol><li>Unilateral</li>
<li>Recurrent</li>
<li>Mild discomfort or blurring of vision</li>
<li>Increased IOP with open angles</li>
<li>Mild anterior chamber reaction or fine white keratic precipitates (KP)</li>
<li>Crises lasting from several hours to weeks</li>
<li>Normal IOP and no signs of uveitis between attacks</li>
<li>Normal visual fields and optic discs<br /></li></ol>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span></h2>
<p>PSS typically affects adults between the age of&#160;20-50 years, although a case of an affected 13-year-old has been reported.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3">&#91;3&#93;</a></sup>&#160;The only study looking at population statistics came out of Finland, which found an incidence of 0.4 and prevalence of 1.9/100,000.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4">&#91;4&#93;</a></sup><br /> 
</p>
<h2><span id="Pathology/Pathophysiology"></span><span class="mw-headline" id="Pathology.2FPathophysiology">Pathology/Pathophysiology</span></h2>
<p>The exact pathophysiology of PSS is still unknown. However, one case of a patient with PSS who underwent trabeculectomy for uncontrolled IOP on medical therapy demonstrated presence of mononuclear cells in the trabecular meshwork of an intra-operative specimen<sup id="cite_ref-Harstad_5-0" class="reference"><a href="#cite_note-Harstad-5">&#91;5&#93;</a></sup>. On electron microscopy, mononuclear cells&#160;were seen intercalated in the trabecular meshwork with long pseudopods, possibly impeding the outflow of aqueous (see Figure 1). The origin of these mononuclear cells is still unknown. 
</p><p><a href="/File:EM_TM_PSS.jpg" class="image" title="Figure 1: (a) Electron microscopy of trabecular meshwork in a PSS patient; (b) higher magnification view [5]."><img alt="Figure 1: (a) Electron microscopy of trabecular meshwork in a PSS patient; (b) higher magnification view [5]." src="/w/images/1/e/e3/EM_TM_PSS.jpg" decoding="async" width="650" height="388" /></a> 
</p><p>Figure 1: (a) Electron microscopy of trabecular meshwork in a PSS patient; (b) higher magnification view.<sup id="cite_ref-Harstad_5-1" class="reference"><a href="#cite_note-Harstad-5">&#91;5&#93;</a></sup> 
</p><p><br /> 
</p><p>See <a href="/w/index.php?title=Possible_Etiologies&amp;action=edit&amp;redlink=1" class="new" title="Possible Etiologies (page does not exist)">Possible Etiologies</a>&#160;for further discussion.<br /><br /> 
</p>
<h1><span class="mw-headline" id="Diagnosis">Diagnosis</span></h1>
<h2><span class="mw-headline" id="History">History</span></h2>
<p>Patients usually present with unilateral blurred vision and mild eye discomfort or pain. There are rare cases reported of a bilateral presentation.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6">&#91;6&#93;</a></sup><sup id="cite_ref-Jap_et_al_7-0" class="reference"><a href="#cite_note-Jap_et_al-7">&#91;7&#93;</a></sup><sup id="cite_ref-8" class="reference"><a href="#cite_note-8">&#91;8&#93;</a></sup><sup id="cite_ref-Teoh_et_al_9-0" class="reference"><a href="#cite_note-Teoh_et_al-9">&#91;9&#93;</a></sup>&#160;In some cases, the patient may not experience any pain. Blurred vision or halos are usually associated with a mild corneal edema caused by elevated IOP. Patients may also endorse a history of prior episodes of blurred vision and eye discomfort that may be suggestive of prior attacks; these episodes may be months to years apart and last from several hours to weeks. The course is variable: some patients may only experience 1 or 2 episodes in their lifetime, whereas some have many recurrences. In general, the frequency of attacks decreases with increasing age. There is usually no inciting event or precursor to attacks. 
</p>
<h2><span class="mw-headline" id="Exam_findings">Exam findings</span></h2>
<p>On exam, the vision can vary from 20/20 to hand motion or light perception depending on the amount of corneal epithelial edema, although the amount of edema is usually mild. The pupil is often slightly dilated or sluggish. The conjunctiva is usually white and quiet, although a mild ciliary flush may be present. There may be small-to-medium, discrete, round, white keratic precipitates on the endothelium, usually in an inferior distribution (see Figure 2). The KPs usually resolve on their own or with anti-inflammatory treatment. The anterior chamber is deep with a mild iritis without significant cell or flare. In the past, iris atrophy or heterochromia has been noted in some cases, but it is not currently considered a characteristic finding for PSS. 
</p><p><br /> 
</p><p><a href="/File:PSS_KPs.jpg" class="image" title="Figure 2: Small, white, discrete keratic precipitates [10]."><img alt="Figure 2: Small, white, discrete keratic precipitates [10]." src="/w/images/1/7/7d/PSS_KPs.jpg" decoding="async" width="216" height="163" /></a><br /> 
</p><p>Figure 2: Small, white, discrete keratic precipitates.<sup id="cite_ref-Chee_et_al_2008_10-0" class="reference"><a href="#cite_note-Chee_et_al_2008-10">&#91;10&#93;</a></sup><br /> 
</p><p><br /> 
</p><p>The IOP is often markedly elevated, usually 40-50 mmHg. Characteristically, IOP elevation is out of proportion to the amount of anterior chamber inflammation, and significant corneal epithelial edema may develop. IOP elevation may last from several hours to weeks and may precede or follow the anterior chamber reaction. 
</p><p>An important criteria for diagnosis is an open angle on gonioscopy. Peripheral anterior synechiae are generally not present despite the presence of anterior chamber inflammation. Early case series have noted the presence of angle abnormalities such as an anteriorly displaced Schwalbe’s line, prominent iris processes, or a fine membrane covering the trabecular meshwork, but these are not considered typical diagnostic features.<sup id="cite_ref-Hart_.26_Weatherill_11-0" class="reference"><a href="#cite_note-Hart_.26_Weatherill-11">&#91;11&#93;</a></sup><sup id="cite_ref-12" class="reference"><a href="#cite_note-12">&#91;12&#93;</a></sup> 
</p><p>The optic nerve can demonstrate acute glaucomatous cupping during an acute attack, as well as decreased perfusion due to the sharp rise in IOP. However, many patients present with normal appearing nerves in an active episode. Cupping&#160;may reverse&#160;after the IOP returns to normal. In cases of repeated attacks over a long period of time, persistent glaucomatous cupping may be observed indicating some degree of permanent damage to the optic nerve. 
</p>
<h2><span class="mw-headline" id="Ancillary_testing">Ancillary testing</span></h2>
<p>Iris angiograms performed during acute attacks demonstrate segmental iris ischemia, vascular congestion and vessel leakage. Interestingly in one case series, iris angiograms performed during the “prodromal phase” when IOP was not elevated also demonstrated focal iris ischemia.<sup id="cite_ref-Raitta_.26_Vannas_13-0" class="reference"><a href="#cite_note-Raitta_.26_Vannas-13">&#91;13&#93;</a></sup> 
</p><p><br />Figure 3: Iris angiogram demonstrating focal iris ischemia during an attack.<sup id="cite_ref-Raitta_.26_Vannas_13-1" class="reference"><a href="#cite_note-Raitta_.26_Vannas-13">&#91;13&#93;</a></sup> 
</p>
<div class="floatleft"><a href="/File:PSS_Iris_Angiogram.jpg" class="image" title="Figure 3: Iris angiogram demonstrating focal iris ischemia during an attack [13]."><img alt="Figure 3: Iris angiogram demonstrating focal iris ischemia during an attack [13]." src="/w/images/1/0/0f/PSS_Iris_Angiogram.jpg" decoding="async" width="555" height="350" /></a></div><p>Optic nerve topography and flowmetry demonstrate transient differences in morphology and blood flow during attacks compared to before/after attacks. Cup volume and area measured by Heidelberg Retinal Tomography increase during an attack, but pre- and post-attack measurements are comparable. Flowmetry may also demonstrate decreased optic nerve perfusion during an attack, particularly at the peripapillary temporal and nasal sectors, as well as at the level of the neuroretinal rim.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14">&#91;14&#93;</a></sup> 
</p><p>Visual fields performed during an attack may demonstrate non-specific changes, but in general, they remain normal following an attack. In patients whom repeated attacks occur, permanent glaucomatous optic nerve damage with accompanying visual field changes may occur<sup id="cite_ref-Jap_et_al_7-1" class="reference"><a href="#cite_note-Jap_et_al-7">&#91;7&#93;</a></sup> and may be an indication for surgical intervention.<br /><br /> 
</p><p><br /> 
</p><p><br /> 
</p><p><a href="/File:PSS_VF.jpg" class="image" title="Figure 4: (a) initial visual field change; (b) visual field progression 2 years later [7]."><img alt="Figure 4: (a) initial visual field change; (b) visual field progression 2 years later [7]." src="/w/images/1/6/68/PSS_VF.jpg" decoding="async" width="654" height="282" /></a> 
</p><p>Figure 4: (a) initial visual field change; (b) visual field progression 2 years later.<sup id="cite_ref-Jap_et_al_7-2" class="reference"><a href="#cite_note-Jap_et_al-7">&#91;7&#93;</a></sup> 
</p>
<h2><span class="mw-headline" id="Laboratory_studies">Laboratory studies</span></h2>
<p>If there is a strong suspicion for a uveitic glaucoma due to viral etiology, laboratory testing for HSV, VZV or CMV titers may be ordered. Viral PCR studies for the same viruses may also be performed on an aqueous tap sample. 
</p>
<h2><span class="mw-headline" id="Associations">Associations</span></h2>
<p>Primary open-angle glaucoma (POAG): Up to a 45% concomitance between PSS and POAG has been reported. Kass et al. described a case series of 11 PSS patients, some of whom demonstrated persistent elevated IOP in the affected eye between episodes, as well as fellow eyes with an elevated IOP.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup>&#160;Five patients demonstrated typical glaucomatous visual field loss, and four developed glaucoma optic nerve change on follow-up.  
</p><p>It has also been suggested, however, that persistent IOP elevation during frequent, recurrent attacks may lead to the same changes. 
</p><p>Non-arteritic ischemic optic neuropathy (NAION): 2 cases of NAION associated with PSS have been reported in the literature.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16">&#91;16&#93;</a></sup><sup id="cite_ref-17" class="reference"><a href="#cite_note-17">&#91;17&#93;</a></sup>&#160;Both patients had a history of hypertension, and one had a “crowded disc” optic nerve morphology. The presumed mechanism is decreased optic disc perfusion due to an acute rise in IOP. Some have suggested that use of prophylactic IOP-lowering drops may decrease the chance of NAION in these patients, however rare it may be.<br /> 
</p>
<h2><span class="mw-headline" id="Differential_diagnosis">Differential diagnosis</span></h2>
<table class="wikitable">
<caption>Table 1: Differential Diagnosis of Posner-Schlossman Syndrome.
</caption>
<tbody><tr>
<td><b>Entity</b>
</td>
<td><b>Differentiating Characteristics</b>
</td></tr>
<tr>
<td>Acute Angle Closure Glaucoma
</td>
<td>Narrow/closed angles on gonioscopy<br />Significant pain and red eye<br />May have significant PAS<br />Mature cataract if pupillary block
</td></tr>
<tr>
<td>Chronic Angle Closure Glaucoma
</td>
<td>Significant PAS on gonioscopy
</td></tr>
<tr>
<td>Primary Open Angle Glaucoma
</td>
<td>Persistently elevated IOP without resolution<br />Lack of anterior chamber inflammation<br />Family history of POAG<br />Glaucomatous-appearing optic nerves<br />Older age
</td></tr>
<tr>
<td>Ocular Hypertension
</td>
<td>Persistently elevated IOP without resolution<br />Lack of anterior chamber inflammation<br />
</td></tr>
<tr>
<td>Uveitic Glaucoma
</td>
<td>Often chronic or more fulminant anterior chamber inflammation
</td></tr>
<tr>
<td>&#160; &#160; &#160;Herpetic Iridocyclitis (HSV, VZV)
</td>
<td>IOP may not be significantly elevated<br />Sectoral/diffuse iris atrophy<br />Stellate KPs, diffuse distribution<br />More robust anterior chamber reaction<br />Vesicular rash<br />Dendritic ulcers
</td></tr>
<tr>
<td>&#160; &#160; &#160;Fuchs Heterochromic Iridocyclitis
</td>
<td>Iris heterochromia, diffuse atrophy<br />Fine abnormal angle vessels on gonioscopy<br />Posterior subcapsular cataract
</td></tr></tbody></table>
<p><br />
</p>
<h1><span class="mw-headline" id="Management">Management</span></h1>
<h2><span class="mw-headline" id="Medical_therapy">Medical therapy</span></h2>
<p>Initial treatment is directed towards controlling intraocular pressure and decreasing inflammation. Typical first-line therapeutics include topical beta-blockers such as timolol, alpha-agonists such as brimonidine, and carbonic anhydrase inhibitors such as dorzolamide. Apraclonidine has also been advocated as a first-line agent.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18">&#91;18&#93;</a></sup><sup id="cite_ref-19" class="reference"><a href="#cite_note-19">&#91;19&#93;</a></sup>&#160;Prostaglandin analogs may also be used, and are effective for IOP control, however it is not firstline as there is evidence suggesting this class of medication might exacerbate inflammation. Oral carbonic anhydrase inhibitors are sometimes used acutely to quickly lower the IOP. 
</p><p>For control of inflammation a topical steroid drop is usually used, such as prednisolone acetate 1% QID, given the typically low level of inflammation. Topical NSAIDs may also be used. Oral NSAIDS such as indomethacin may also be used to avoid a possible steroid-induced glaucoma and for their anti-prostaglandin properties, as elevated prostaglandin levels in the aqueous have been associated with attacks.<sup id="cite_ref-Masuda_et_al_20-0" class="reference"><a href="#cite_note-Masuda_et_al-20">&#91;20&#93;</a></sup> 
</p><p>Miotics and mydriatic agents are rarely used. In particular, pilocarpine should be avoided as this is thought to exacerbate a possible trabeculitis. 
</p>
<h2><span class="mw-headline" id="Surgical_therapy">Surgical therapy</span></h2>
<p>In cases where the IOP cannot be controlled using maximal medical therapy, surgical therapy may be considered, especially when signs of glaucomatous optic nerve damage or visual field changes appear.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21">&#91;21&#93;</a></sup>&#160;One case series reported 8 patients with PSS who underwent trabeculectomy with mitomycin-C for uncontrolled IOPs and visual field defects. At the end of follow-up, all patients did not require IOP-lowering drops, and although a recurrence of iritis was noted in 2 patients, the IOP remained stable during the episodes.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22">&#91;22&#93;</a></sup> 
</p>
<h2><span class="mw-headline" id="Follow_up">Follow up</span></h2>
<p>Patients should be followed daily until their IOP return to baseline, then weekly as anti-glaucoma drops and topical steroids are tapered. Well-educated and informed patients may also be able to initiate self-treatment with topical drops if they notice signs and symptoms of an impending or active attack, but should also be instructed to follow up immediately with an ophthalmologist. 
</p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span></h2>
<p>Posner-Schlossman Syndrome has long thought to be a “benign” disease; most patients are treated for attacks and recover without long-term sequelae. However, a number of patients with repeated attacks, even if treated, may show long term glaucomatous changes in the optic nerve and on visual field testing. <sup id="cite_ref-Jap_et_al_7-3" class="reference"><a href="#cite_note-Jap_et_al-7">&#91;7&#93;</a></sup> It is thought that it is the total duration of elevated IOP, not the frequency of attacks, that contributes to the damage. These patients may be candidates for surgical therapy as discussed above. 
</p>
<h1><span class="mw-headline" id="Possible_Etiologies">Possible Etiologies</span></h1>
<p>A number of theories have been proposed as causative and/or contributory factors to PSS. Some are no longer considered accurate, but much work remains in elucidating the causative factor. 
</p>
<h2><span class="mw-headline" id="Autonomic_dysregulation">Autonomic dysregulation<br /></span></h2>
<p>Posner and Schlossman first postulated that glaucomatocyclitic crisis was a result of autonomic dysregulation; they noted that 4 patients in their original 1948 case series also had a history of migraines.<sup id="cite_ref-PosnerSchlossman_1-1" class="reference"><a href="#cite_note-PosnerSchlossman-1">&#91;1&#93;</a></sup>&#160;In 1977, Raita and Vannas performed iris angiograms on a series of PSS patients and found that not only was there focal iris ischemia during attacks, but during the prodromal, normotensive, phase, ischemia was also present.<sup id="cite_ref-Raitta_.26_Vannas_13-2" class="reference"><a href="#cite_note-Raitta_.26_Vannas-13">&#91;13&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Allergy">Allergy</span></h2>
<p>In early case series of PSS patients, associations with allergic conditions have been noted. The term “glaucoma allergicum” was first coined by Kraupa in 1935 when he described 4 cases of recurrent unilateral inflammation and glaucoma.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23">&#91;23&#93;</a></sup>&#160;In Posner and Schlossman’s original case series, 2 patients had hay fever, 2 had asthma, and 2 had concurrent urticaria on the same side of the face as the glaucoma, although the authors made a point that their findings did not corroborate or disprove Kraupa’s theory.<sup id="cite_ref-PosnerSchlossman_1-2" class="reference"><a href="#cite_note-PosnerSchlossman-1">&#91;1&#93;</a></sup>&#160;Subsequent case series also noted pre- or co-existing allergic conditions in patients<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">&#91;24&#93;</a></sup><sup id="cite_ref-25" class="reference"><a href="#cite_note-25">&#91;25&#93;</a></sup> and one reported case where the frequency and severity of attacks decrease with “injections” for ragweed and grass allergies.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26">&#91;26&#93;</a></sup>&#160;In general, allergy is not currently considered a leading theory.
</p>
<h2><span class="mw-headline" id="Variation_of_developmental_glaucoma">Variation of developmental glaucoma</span></h2>
<p>Another theory that has fallen by the wayside is that PSS is a variant of developmental glaucoma. In early case series in the 1950s/60s, this theory was based on the observation of bilateral angle abnormalities on gonioscopy during attacks. Features such as abnormal iris processes, anteriorized Schwalbe’s line, and a “grey membrane” covering the trabecular meshwork have been described.<sup id="cite_ref-Hart_.26_Weatherill_11-1" class="reference"><a href="#cite_note-Hart_.26_Weatherill-11">&#91;11&#93;</a></sup><sup id="cite_ref-27" class="reference"><a href="#cite_note-27">&#91;27&#93;</a></sup><sup id="cite_ref-28" class="reference"><a href="#cite_note-28">&#91;28&#93;</a></sup>&#160;It is now generally agreed that the angle morphology is normal, without obvious abnormalities, and this theory has not been given much credence. 
</p>
<h2><span class="mw-headline" id="Vascular_endothelial_dysfunction">Vascular endothelial dysfunction</span></h2>
<p>Similar to the theory of autonomic dysregulation, vascular endothelial dysfunction has also been proposed. This has been supported by evidence suggesting ciliary vascular abnormalities, such as focal iris ischemia and leakage from iris/ciliary blood vessels on angiogram during attacks. This is also based on the fact that other studies have shown abnormal flow-mediated vasodilation in other types of glaucoma.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">&#91;29&#93;</a></sup><sup id="cite_ref-30" class="reference"><a href="#cite_note-30">&#91;30&#93;</a></sup>&#160;A recent case series of 12 PSS patients by Shen et al. demonstrated significant peripheral vascular endothelial dysfunction compared to an age-matched control group.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31">&#91;31&#93;</a></sup>&#160;This underlying vascular endothelial abnormality may explain the propensity for glaucomatous optic nerve damage in the long run. While more work is currently being done in this area, possible future treatments, if this theory holds true, may seek to address endothelial dysfunction with cardiovascular therapies such aspirin, etc. 
</p>
<h2><span id="Autoimmune/HLA-Bw54"></span><span class="mw-headline" id="Autoimmune.2FHLA-Bw54">Autoimmune/HLA-Bw54</span></h2>
<p>Prostaglandins have been implicated in uveitic conditions including glaucomatocyclitic crises. The level of evidence for this association, however, is limited to a few animals studies. The mechanism of IOP elevation in glaucomatoucyclitic crises has been thought to be due to a decrease in outflow facility as well as an increase in aqueous production&#160;<sup id="cite_ref-32" class="reference"><a href="#cite_note-32">&#91;32&#93;</a></sup>. In animal models, prostaglandins have been shown to  exacerbate breakdown of the blood-aqueous barrier, allowing inflammatory cells into the anterior chamber leading to clogging of the trabecular meshwork. Elevated prostaglandin levels, particularly PGE2, have been found in the aqueous during attacks and levels positively correlate with IOP.<sup id="cite_ref-Masuda_et_al_20-1" class="reference"><a href="#cite_note-Masuda_et_al-20">&#91;20&#93;</a></sup><sup id="cite_ref-33" class="reference"><a href="#cite_note-33">&#91;33&#93;</a></sup>&#160;The same study also demonstrated an IOP-lowering effect with indomethacin treatment, a prostaglandin inhibitor. 
</p><p>One study of a Japanese cohort of 22 PSS patients found that 41% had HLA-Bw54 haplotype vs. 8% of controls.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34">&#91;34&#93;</a></sup>&#160;HLA-Bw54 has also been implicated in Voyt-Koyanagi-Harada syndrome and while it may not necessarily a causative gene, it may be linked through linkage dysequilibrium to a causative gene or indicate an underlying susceptibility to the syndrome. Interestingly, in this same study, HLA-Bw52 was found in 21% of controls, whereas none of the PSS cohort demonstrated HLA-Bw52 positivity, suggesting a protective effect of the haplotype. 
</p>
<h2><span class="mw-headline" id="Infectious">Infectious</span></h2>
<h3><span class="mw-headline" id="H._pylori"><i>H. pylori</i></span></h3>
<p>An association between H. pylori antibodies and anterior uveitis has been proposed in the past.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35">&#91;35&#93;</a></sup>&#160;The two diseases also affect a similar age distribution. Knox first noted an association between PSS and peptic ulcer disease (PUD) in a case series of 32 patients, where 38% of females and 68% of males also had PUD vs. a normal incidence of 5% and 10-20%, respectively.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36">&#91;36&#93;</a></sup>&#160;A prospective study also confirmed an association between the presence of anti-H. pylori serum IgG and PSS.<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">&#91;37&#93;</a></sup>&#160;It has been suggested that there may be some cross-reactivity or -antigenicity between intestinal mucosa and the contents of the anterior chamber or trabecular meshwork that may predispose PUD patients to PSS. 
</p>
<h3><span id="HSV/VZV"></span><span class="mw-headline" id="HSV.2FVZV">HSV/VZV</span></h3>
<p>Both HSV and VZV have been proposed in the past as possible infectious culprits underlying PSS.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38">&#91;38&#93;</a></sup>&#160;VZV was the first infectious agent proposed in 1985, with one study demonstrating an association between the level of varicella immunity and frequency of PSS attacks.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39">&#91;39&#93;</a></sup>&#160;However, subsequent case series have failed to demonstrate this association in other tests, such as VZV PCR. One case series demonstrated HSV PCR positivity in aqueous samples collected during attacks,<sup id="cite_ref-40" class="reference"><a href="#cite_note-40">&#91;40&#93;</a></sup>&#160;but subsequent case series have failed to replicate these findings. Furthermore, acyclovir has been found to be ineffective in treating or preventing PSS. 
</p>
<h3><span class="mw-headline" id="CMV">CMV</span></h3>
<p>Several studies have been published examining the possible role of CMV in PSS. Studies have found active CMV-antibody production occurring in a significant number of PSS patients,<sup id="cite_ref-41" class="reference"><a href="#cite_note-41">&#91;41&#93;</a></sup>&#160;and small case series/reports have suggested an association.<sup id="cite_ref-Teoh_et_al_9-1" class="reference"><a href="#cite_note-Teoh_et_al-9">&#91;9&#93;</a></sup><sup id="cite_ref-Markomichelakis_42-0" class="reference"><a href="#cite_note-Markomichelakis-42">&#91;42&#93;</a></sup><sup id="cite_ref-de_Schryver_43-0" class="reference"><a href="#cite_note-de_Schryver-43">&#91;43&#93;</a></sup><sup id="cite_ref-Rodier-Bonifas_44-0" class="reference"><a href="#cite_note-Rodier-Bonifas-44">&#91;44&#93;</a></sup>&#160; Larger-scale studies in Singaporean cohorts have supported an association between CMV and PSS,<sup id="cite_ref-Chee_et_al_2008_10-1" class="reference"><a href="#cite_note-Chee_et_al_2008-10">&#91;10&#93;</a></sup><sup id="cite_ref-45" class="reference"><a href="#cite_note-45">&#91;45&#93;</a></sup>&#160;and there have been some reports of response to and questionable prophylactic benefit of anti-viral therapy specific to CMV such as cidofovir, foscarnet and valganciclovir.<sup id="cite_ref-Teoh_et_al_9-2" class="reference"><a href="#cite_note-Teoh_et_al-9">&#91;9&#93;</a></sup><sup id="cite_ref-Markomichelakis_42-1" class="reference"><a href="#cite_note-Markomichelakis-42">&#91;42&#93;</a></sup><sup id="cite_ref-de_Schryver_43-1" class="reference"><a href="#cite_note-de_Schryver-43">&#91;43&#93;</a></sup><sup id="cite_ref-Rodier-Bonifas_44-1" class="reference"><a href="#cite_note-Rodier-Bonifas-44">&#91;44&#93;</a></sup><sup id="cite_ref-46" class="reference"><a href="#cite_note-46">&#91;46&#93;</a></sup>&#160;It remains to be seen whether the response or prophylaxis achieved by these antivirals represents a true treatment response or the normal history of PSS, which by definition is self-resolving.<br /> 
</p>
<h1><span class="mw-headline" id="References">References</span></h1>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-PosnerSchlossman-1"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-PosnerSchlossman_1-0">1.0</a></sup> <sup><a href="#cite_ref-PosnerSchlossman_1-1">1.1</a></sup> <sup><a href="#cite_ref-PosnerSchlossman_1-2">1.2</a></sup></span> <span class="reference-text">Posner A, Schlossman A. "Syndrome of unilateral recurrent attacks of glaucoma with cyclitic symptoms." <i>Arch Ophthalmol.</i> 1948 Apr;39(4):517-35.</span>
</li>
<li id="cite_note-2"><span class="mw-cite-backlink"><a href="#cite_ref-2">↑</a></span> <span class="reference-text">Posner A, Schlossman A. "Further observations on the syndrome of glaucomatocyclitic crisis." <i>Trans Am Acad Ophthalmol Otolaryngol.</i> 1953;57:531.</span>
</li>
<li id="cite_note-3"><span class="mw-cite-backlink"><a href="#cite_ref-3">↑</a></span> <span class="reference-text">Burnstein Y, Shelton K, Higginbotham EJ. "Glaucomatocyclitic crisis in a child." <i>Am J Ophthalmol.</i> 1998 Jul;126(1):136-7.</span>
</li>
<li id="cite_note-4"><span class="mw-cite-backlink"><a href="#cite_ref-4">↑</a></span> <span class="reference-text">Paivonsalo-Hietanen T, Tuominen J, Vaahtoranta-Lehtonen H, et al. "Incidence and prevalence of different uveitis entities in Finland." <i>Acta Ophthalmol Scand.</i> Feb 1997;75(1):76-81.</span>
</li>
<li id="cite_note-Harstad-5"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-Harstad_5-0">5.0</a></sup> <sup><a href="#cite_ref-Harstad_5-1">5.1</a></sup></span> <span class="reference-text">Harstad HK, Ringvold A. "Glaucomatocyclitic crises (Posner-Schlossman syndrome). A case report." <i>Acta Ophthalmol (Copenh).</i> Apr 1986;64(2):146-51.</span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><a href="#cite_ref-6">↑</a></span> <span class="reference-text">Levatin P. "Glaucomatocyclitic crisis occurring in both eyes." Am J Ophthalmol. 1956;41:1056.fckLR7. Jap A, Sivakumar M, Chee SP. "Is Posner Schlossman syndrome benign?." <i>Ophthalmology.</i> May 2001;108(5):913-8.</span>
</li>
<li id="cite_note-Jap_et_al-7"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-Jap_et_al_7-0">7.0</a></sup> <sup><a href="#cite_ref-Jap_et_al_7-1">7.1</a></sup> <sup><a href="#cite_ref-Jap_et_al_7-2">7.2</a></sup> <sup><a href="#cite_ref-Jap_et_al_7-3">7.3</a></sup></span> <span class="reference-text">Jap A, Sivakumar M, Chee SP. "Is Posner Schlossman syndrome benign?." <i>Ophthalmology.</i> May 2001;108(5):913-8.</span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><a href="#cite_ref-8">↑</a></span> <span class="reference-text">Dinakaran S, Kayarkar V. "Trabeculectomy in the management of Posner-Schlossman syndrome." <i>Ophthalmic Surg Lasers.</i> Jul-Aug 2002;33(4):321-2.</span>
</li>
<li id="cite_note-Teoh_et_al-9"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-Teoh_et_al_9-0">9.0</a></sup> <sup><a href="#cite_ref-Teoh_et_al_9-1">9.1</a></sup> <sup><a href="#cite_ref-Teoh_et_al_9-2">9.2</a></sup></span> <span class="reference-text">Teoh SB, Thean L, Koay E. "Cytomegalovirus in aetiology of Posner-Schlossman syndrome: evidence from quantitative polymerase chain reaction." <i>Eye.</i> Dec 2005;19(12):1338-40.</span>
</li>
<li id="cite_note-Chee_et_al_2008-10"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-Chee_et_al_2008_10-0">10.0</a></sup> <sup><a href="#cite_ref-Chee_et_al_2008_10-1">10.1</a></sup></span> <span class="reference-text">Chee SP, Bacsal K, Jap A, Se-Thoe SY, Cheng CL, Tan BH. "Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients." <i>Am J Ophthalmol.</i> May 2008;145(5):834-40.</span>
</li>
<li id="cite_note-Hart_.26_Weatherill-11"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-Hart_.26_Weatherill_11-0">11.0</a></sup> <sup><a href="#cite_ref-Hart_.26_Weatherill_11-1">11.1</a></sup></span> <span class="reference-text">Hart CT, Weatherill JR. "Gonioscopy and tonography in glaucomatocyclitic crises." <i>Br J Ophthalmol.</i> Sep 1968;52(9):682-7.</span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><a href="#cite_ref-12">↑</a></span> <span class="reference-text">Gorin G. "Developmental glaucoma: a concept based on correlation of gonioscopic findings with clinical manifestations." <i>Am J Ophthalmol.</i> 1964;58:572-579.</span>
</li>
<li id="cite_note-Raitta_.26_Vannas-13"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-Raitta_.26_Vannas_13-0">13.0</a></sup> <sup><a href="#cite_ref-Raitta_.26_Vannas_13-1">13.1</a></sup> <sup><a href="#cite_ref-Raitta_.26_Vannas_13-2">13.2</a></sup></span> <span class="reference-text">Raitta C, Vannas A. "Glaucomatocyclitic crisis." <i>Arch Ophthalmol.</i> 1977;95:608.</span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><a href="#cite_ref-14">↑</a></span> <span class="reference-text">Darchuk V, Sampaolesi J, Mato L, et al. "Optic nerve head behavior in Posner-Schlossman syndrome." <i>Int Ophthalmol.</i> 2001;23(4-6):373-9.</span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><a href="#cite_ref-15">↑</a></span> <span class="reference-text">Kass MA, Becker B, Kolker AE. "Glaucomatocyclitic crisis and primary open-angle glaucoma." <i>Am J Ophthalmol.</i> Apr 1973;75(4):668-73.</span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><a href="#cite_ref-16">↑</a></span> <span class="reference-text">Kim R, Van Stavern G, Juzych M. "Nonarteritic anterior ischemic optic neuropathy associated with acute glaucoma secondary to Posner-Schlossman syndrome." <i>Arch Ophthalmol.</i> Jan 2003;121(1):127-8.</span>
</li>
<li id="cite_note-17"><span class="mw-cite-backlink"><a href="#cite_ref-17">↑</a></span> <span class="reference-text">Irak I, Katz BJ, Zabriskie NA, et al. "Posner-Schlossman syndrome and nonarteritic anterior ischemic optic neuropathy." <i>J Neuroophthalmol.</i> Dec 2003;23(4):264-7.</span>
</li>
<li id="cite_note-18"><span class="mw-cite-backlink"><a href="#cite_ref-18">↑</a></span> <span class="reference-text">Muthusamy P. "Apraclonidine in the management of glaucomatocyclitic crisis." <i>Eye.</i> 1994;8(Pt 3):367-8.</span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><a href="#cite_ref-19">↑</a></span> <span class="reference-text">Hong C, Song KY. "Effect of apraclonidine hydrochloride on the attack of Posner-Schlossman syndrome." <i>Korean J Ophthalmol.</i> 1993 Jun;7(1):28-33.</span>
</li>
<li id="cite_note-Masuda_et_al-20"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-Masuda_et_al_20-0">20.0</a></sup> <sup><a href="#cite_ref-Masuda_et_al_20-1">20.1</a></sup></span> <span class="reference-text">Masuda K, Izawa Y, Mishima S. "Prostaglandins and glaucomatocyclitic crisis." <i>Jpn J Ophthalmol.</i> 1975;19:368.</span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><a href="#cite_ref-21">↑</a></span> <span class="reference-text">Hung PT, Chang JM. "Treatment of glaucomatocyclitic crises." <i>Am J Ophthalmol.</i> 1974;77:169–172.</span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><a href="#cite_ref-22">↑</a></span> <span class="reference-text">Zhong Y, Cheng Y, Liu X, Feng P. "Trabeculectomy in the management of glaucomatocyclitic crisis with visual field defect." <i>Ocul Immunol Inflamm.</i> 2010;18(3):233-6.</span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><a href="#cite_ref-23">↑</a></span> <span class="reference-text">Kraupa E. "Die Drucksteigerung bei akuter Angioneurose des Ciliarkörpers ('Glaucoma allergicum') in ihren Beziehungen zum zyklitischen und Heterechromieglaukom." <i>Arch Augenheilkd.</i> 1936;109:416-433.</span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><a href="#cite_ref-24">↑</a></span> <span class="reference-text">Theodore FH. "Observations on glaucomatocyclitic crises (Posner-Schlossman syndrome)." <i>Br J Ophthalmol.</i> 1952 Apr;36(4):207-10.</span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><a href="#cite_ref-25">↑</a></span> <span class="reference-text">Posner A. "The syndrome of glaucomatocyclitic crises." <i>Eye Ear Nose Throat Mon.</i> 1952 Jan;31(1):41-2.</span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><a href="#cite_ref-26">↑</a></span> <span class="reference-text">Kornzweig AL. "Glaucomatous cyclitic crises." <i>Am J Ophthalmol.</i> 1953 Jan;36(1):123-4.</span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><a href="#cite_ref-27">↑</a></span> <span class="reference-text">Sokolic P. "Another case with recurrent glaucomatocyclitic crisis and anomalies in chamber angle, observed during and between hypertensive episodes. Contribution to etiology." <i>Acta Ophthalmol (Copenh).</i> 1969;47(5):1129-34.</span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><a href="#cite_ref-28">↑</a></span> <span class="reference-text">Sokolić P. "Developmental factor in the etiopathogenesis of glaucomatocyclitic crisis." <i>Ophthalmologica.</i> 1970;161(5):446-50.</span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><a href="#cite_ref-29">↑</a></span> <span class="reference-text">Su WW, Cheng ST, Hsu TS, Ho WJ. "Abnormal flow-mediated vasodilation in normal-tension glaucoma using a noninvasive determination for peripheral endothelial dysfunction." <i>Invest Ophthalmol Vis Sci.</i> 2006 Aug;47(8):3390-4.</span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><a href="#cite_ref-30">↑</a></span> <span class="reference-text">Su WW, Cheng ST, Ho WJ, Tsay PK, Wu SC, Chang SH. "Glaucoma is associated with peripheral vascular endothelial dysfunction." <i>Ophthalmology.</i> 2008 Jul;115(7):1173-1178.</span>
</li>
<li id="cite_note-31"><span class="mw-cite-backlink"><a href="#cite_ref-31">↑</a></span> <span class="reference-text">Shen SC, Ho WJ, Wu SC, Yu KH, Lin HC, Lin YS, Tsay PK, Chu PH. "Peripheral vascular endothelial dysfunction in glaucomatocyclitic crisis: a preliminary study." <i>Invest Ophthalmol Vis Sci.</i> 2010 Jan;51(1):272-6.</span>
</li>
<li id="cite_note-32"><span class="mw-cite-backlink"><a href="#cite_ref-32">↑</a></span> <span class="reference-text">Nagataki S, Mishima J. "Aqueous humor dynamics in glaucomatocyclitic crisis." <i>Invest Ophthalmol.</i> 1976;15:365.</span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><a href="#cite_ref-33">↑</a></span> <span class="reference-text">Eakins KE. "Increased intraocular pressure produced by prostaglandins E1 and E2 in the cat eye." <i>Exp Eye Res.</i> Jul 1970;10(1):87-92.</span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><a href="#cite_ref-34">↑</a></span> <span class="reference-text">Hirose S, Ohno S, Matsuda H. "HLA-Bw54 and glaucomatocyclitic crisis." <i>Arch Ophthalmol.</i> Dec 1985;103(12):1837-9.</span>
</li>
<li id="cite_note-35"><span class="mw-cite-backlink"><a href="#cite_ref-35">↑</a></span> <span class="reference-text">Otasevic L, Walduck A, Meyer TF, Aebischer T, Hartmann C, Orlic N, Pleyer U. "Helicobacter pylori infection in anterior uveitis." <i>Infection.</i> 2005 Apr;33(2):82-5.</span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><a href="#cite_ref-36">↑</a></span> <span class="reference-text">Knox DL. "Glaucomatocyclitic crises and systemic disease: peptic ulcer, other gastrointestinal disorders, allergy and stress." <i>Trans Am Ophthalmol Soc.</i> 1988;86:473-95.</span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><a href="#cite_ref-37">↑</a></span> <span class="reference-text">Choi CY, Kim MS, Kim JM, Park SH, Park KH, Hong C. "Association between Helicobacter pylori infection and Posner-Schlossman syndrome." <i>Eye (Lond).</i> Jan 2010;24(1):64-9.</span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><a href="#cite_ref-38">↑</a></span> <span class="reference-text">Takusagawa HL, Liu Y, Wiggs JL. "Infectious theories of Posner-Schlossman syndrome." <i>Int Ophthalmol Clin.</i> Fall 2011;51(4):105-15.</span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><a href="#cite_ref-39">↑</a></span> <span class="reference-text">Tanaka Y, Harion S, Hara J. "Cellular immunity as judged by varicella skin test in Posner-Schlossman syndrome in patients." <i>Folia Jpn.</i> 1985;36:972-976.</span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><a href="#cite_ref-40">↑</a></span> <span class="reference-text">Yamamoto S, Pavan-Langston D, Tada R, et al. "Possible role of herpes simplex virus in the origin of Posner-Schlossman syndrome." <i>Am J Ophthalmol.</i> Jun 1995;119(6):796-8.</span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><a href="#cite_ref-41">↑</a></span> <span class="reference-text">Bloch-Michel E, Dussaix E, Cerqueti P, et al. "Possible role of cytomegalovirus infection in the etiology of the Posner-Schlossmann syndrome." <i>Int Ophthalmol.</i> Dec 1987;11(2):95-6.</span>
</li>
<li id="cite_note-Markomichelakis-42"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-Markomichelakis_42-0">42.0</a></sup> <sup><a href="#cite_ref-Markomichelakis_42-1">42.1</a></sup></span> <span class="reference-text">Markomichelakis NN, Canakis C, Zafirakis P, Marakis T, Mallias I, Theodossiadis G. "Cytomegalovirus as a cause of anterior uveitis with sectoral iris atrophy." <i>Ophthalmology.</i> 2002 May;109(5):879-82.</span>
</li>
<li id="cite_note-de_Schryver-43"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-de_Schryver_43-0">43.0</a></sup> <sup><a href="#cite_ref-de_Schryver_43-1">43.1</a></sup></span> <span class="reference-text">de Schryver I, Rozenberg F, Cassoux N, Michelson S, Kestelyn P, Lehoang P, Davis JL, Bodaghi B. "Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis." <i>Br J Ophthalmol.</i> 2006 Jul;90(7):852-5.</span>
</li>
<li id="cite_note-Rodier-Bonifas-44"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-Rodier-Bonifas_44-0">44.0</a></sup> <sup><a href="#cite_ref-Rodier-Bonifas_44-1">44.1</a></sup></span> <span class="reference-text">Rodier-Bonifas C, Cornut PL, Billaud G, Lina B, Burillon C, Denis P. "Cytomegalovirus research using polymerase chain reaction in Posner-Schlossman syndrome." <i>J Fr Ophtalmol.</i> 2011 Jan;34(1):24-9.</span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><a href="#cite_ref-45">↑</a></span> <span class="reference-text">Chee SP, Jap A. "Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes." <i>Am J Ophthalmol.</i> 2008 Dec;146(6):883-9.e1.</span>
</li>
<li id="cite_note-46"><span class="mw-cite-backlink"><a href="#cite_ref-46">↑</a></span> <span class="reference-text">Chee SP, Jap A. "Cytomegalovirus anterior uveitis: outcome of treatment." <i>Br J Ophthalmol.</i> 2010 Dec;94(12):1648-52.</span>
</li>
</ol></div>
<!-- 
NewPP limit report
Cached time: 20230306035153
Cache expiry: 86400
Dynamic content: false
Complications: [my_variables_no_cache]
[SMW] In‐text annotation parser time: 0.023 seconds
CPU time usage: 0.302 seconds
Real time usage: 1.981 seconds
Preprocessor visited node count: 1340/1000000
Post‐expand include size: 10473/2097152 bytes
Template argument size: 2191/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 1/100
Unstrip recursion depth: 0/20
Unstrip post‐expand size: 21039/5000000 bytes
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00% 1000.261      1 -total
 88.24%  882.584      1 Template:Article
 81.90%  819.216      6 Template:Infobox_section
 34.00%  340.096     13 Template:UserLookup
 11.76%  117.592      1 Template:Infobox_disease
  3.94%   39.384      1 Template:Review_expired
  0.84%    8.395      1 Template:Get_active_contest
  0.15%    1.536      2 Template:Infobox_begin
  0.09%    0.872      2 Template:Infobox_end
-->
</div></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://eyewiki.org/w/index.php?title=Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)&amp;oldid=85387">https://eyewiki.org/w/index.php?title=Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)&amp;oldid=85387</a>"</div>

						<!-- end body text -->
						<!-- data blocks which should go somewhere after the body text, but not before the catlinks block-->
						<div id='mw-data-after-content'>
	<div class="mw-cookiewarning-container"><div class="mw-cookiewarning-text"><span>The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.</span></div><form method="POST"><div class='oo-ui-layout oo-ui-horizontalLayout'><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-progressive oo-ui-buttonWidget'><a role='button' tabindex='0' aria-disabled='false' href='https://www.aao.org/privacy-policy' rel='nofollow' class='oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-progressive'></span><span class='oo-ui-labelElement-label'>Learn more</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-progressive'></span></a></span><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-inputWidget oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-primary oo-ui-flaggedElement-progressive oo-ui-buttonInputWidget'><button type='submit' tabindex='0' aria-disabled='false' name='disablecookiewarning' value='OK' class='oo-ui-inputWidget-input oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-invert'></span><span class='oo-ui-labelElement-label'>Accept</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-invert'></span></button></span></div></form></div>
</div>

					</div>
					<!-- category links -->
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/Special:Categories" title="Special:Categories">Categories</a>: <ul><li><a href="/Category:Articles" title="Category:Articles">Articles</a></li><li><a href="/Category:Glaucoma" title="Category:Glaucoma">Glaucoma</a></li><li><a href="/Category:Uveitis" title="Category:Uveitis">Uveitis</a></li></ul></div></div>
				</div>
			</div>
		</div>
	</div>
	<div class="mb-2 mt-4 footer container">
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar not-collapsible small mb-2" role="navigation" id="mw-navigation-hbpzyuuvk0">
					<div class="navbar-nav">
					<!-- toolbox -->
					<div id="t-whatlinkshere" class="nav-item"><a href="/Special:WhatLinksHere/Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)" title="A list of all wiki pages that link here [j]" accesskey="j" class="nav-link t-whatlinkshere">What links here</a></div>
					<div id="t-recentchangeslinked" class="nav-item"><a href="/Special:RecentChangesLinked/Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k" class="nav-link t-recentchangeslinked">Related changes</a></div>
					<div id="t-specialpages" class="nav-item"><a href="/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q" class="nav-link t-specialpages">Special pages</a></div>
					<div id="t-print" class="nav-item"><a href="javascript:print();" rel="alternate" title="Printable version of this page [p]" accesskey="p" class="nav-link t-print">Printable version</a></div>
					<div id="t-permalink" class="nav-item"><a href="/w/index.php?title=Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)&amp;oldid=85387" title="Permanent link to this revision of the page" class="nav-link t-permalink">Permanent link</a></div>
					<div id="t-info" class="nav-item"><a href="/w/index.php?title=Glaucomatocyclitic_Crisis_(Posner-Schlossman_Syndrome)&amp;action=info" title="More information about this page" class="nav-link t-info">Page information</a></div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- footer links -->
				<div id="footer-info" class="footer-info">
					<!-- info -->
					<div> This page was last edited on September 28, 2022, at 14:43.</div>
					<div>This page has been accessed 468,702 times.</div>
				</div>
				<!-- places -->
				<div id="footer-places" class="footer-places">
					<div><a href="/EyeWiki:Privacy_policy" title="EyeWiki:Privacy policy">Privacy policy</a></div>
					<div><a href="/EyeWiki:About" title="EyeWiki:About">About EyeWiki</a></div>
					<div><a href="/EyeWiki:General_disclaimer" title="EyeWiki:General disclaimer">Disclaimers</a></div>
				</div>
			</div>
			<div class="col">
				<!-- footer icons -->
				<div id="footer-icons" class="justify-content-end footer-icons">
					<!-- poweredby -->
					<div><a href="https://www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></div>
					<div><a href="https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki"><img src="data:image/png;base64,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" alt="Powered by Semantic MediaWiki" class="smw-footer" width="88" height="31" loading="lazy"/></a></div>
				</div>
			</div>
		</div>
	</div>
<script src="https://www.googletagmanager.com/gtag/js?id=UA-64665049-1" async=""></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-64665049-1', {});
</script>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"smw":{"limitreport-intext-parsertime":0.023},"limitreport":{"cputime":"0.302","walltime":"1.981","ppvisitednodes":{"value":1340,"limit":1000000},"postexpandincludesize":{"value":10473,"limit":2097152},"templateargumentsize":{"value":2191,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":1,"limit":100},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":21039,"limit":5000000},"timingprofile":["100.00% 1000.261      1 -total"," 88.24%  882.584      1 Template:Article"," 81.90%  819.216      6 Template:Infobox_section"," 34.00%  340.096     13 Template:UserLookup"," 11.76%  117.592      1 Template:Infobox_disease","  3.94%   39.384      1 Template:Review_expired","  0.84%    8.395      1 Template:Get_active_contest","  0.15%    1.536      2 Template:Infobox_begin","  0.09%    0.872      2 Template:Infobox_end"]},"cachereport":{"timestamp":"20230306035153","ttl":86400,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":2569});});</script></body>
</html>